CanniMed Therapeutics Inc. (TSE:CMED – Get Free Report) shares dropped 5.3% during trading on Monday . The company traded as low as C$27.00 and last traded at C$27.00. Approximately 52,208 shares were traded during trading, a decline of 87% from the average daily volume of 387,394 shares. The stock had previously closed at C$28.50.
CanniMed Therapeutics Stock Down 5.3 %
The business has a 50 day simple moving average of C$27.00.
CanniMed Therapeutics Company Profile
CanniMed Therapeutics Inc operates as a plant biopharmaceutical company that specializes in medical cannabis. The company cultivates and sells pharmaceutical-grade cannabis products in dried herbal and oil forms for Canadian patients. It also offers herbal cannabis and cannabis oil; and vaporizers, consumable vaporizer accessories, and herb mills.
See Also
- Five stocks we like better than CanniMed Therapeutics
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Intel: Is Now the Time to Be Brave?
- How to buy stock: A step-by-step guide for beginners
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- 3 Monster Growth Stocks to Buy Now
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for CanniMed Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanniMed Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
